Oculis Holding AG (OCS) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $7.29, -1.49% vs the prior close of $7.40.
- Volume 293.68K shares, 1.2x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
OCS dips 1.5% to $7.29. Closed at $7.29, -1.49% vs the prior close of $7.40. Day range $7.16–$7.46, opened at $7.33.
OCS daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — OCS dips 1.5% to $7.29
- Closed at $7.29, -1.49% vs the prior close of $7.40. Day range $7.16–$7.46, opened at $7.33.
- Volume was 293.68K shares, 1.2x its 50-day average of 245.17K.
- Price is -32.3% vs its 50-day average ($10.77) and -62.6% vs its 200-day average ($19.51).
- 52-week range $7.11–$34.47; today's close sits at 1% of that range, 78.9% below the 52-week high.
Oct 15, 2026 — OCS jumps 3.2% to $7.40 on 2.3x normal volume
- Closed at $7.40, +3.21% vs the prior close of $7.17. Day range $7.15–$7.60, opened at $7.25.
- Volume was 559.20K shares, 2.3x its 50-day average of 245.57K — unusually heavy trading.
- Price is -31.9% vs its 50-day average ($10.87) and -62.2% vs its 200-day average ($19.57).
- 52-week range $7.11–$34.47; today's close sits at 1% of that range, 78.5% below the 52-week high.
Oct 14, 2026 — OCS slides 5.9% to $7.17, a 52-week low on 2.1x normal volume
- Closed at $7.17, -5.91% vs the prior close of $7.62. Day range $7.11–$7.74, opened at $7.51.
- Volume was 511.40K shares, 2.1x its 50-day average of 241.57K — unusually heavy trading.
- Price is -34.6% vs its 50-day average ($10.96) and -63.5% vs its 200-day average ($19.64).
- 52-week range $7.11–$34.47; today's close sits at 0% of that range, 79.2% below the 52-week high.
- That makes 4 straight losses.
Oct 13, 2026 — OCS slides 3.3% to $7.62, a 52-week low, 3 down days in a row
- Closed at $7.62, -3.30% vs the prior close of $7.88. Day range $7.32–$7.84, opened at $7.84.
- Volume was 320.20K shares, 1.3x its 50-day average of 241.08K.
- Price is -31.1% vs its 50-day average ($11.06) and -61.3% vs its 200-day average ($19.70).
- 52-week range $7.32–$34.47; today's close sits at 1% of that range, 77.9% below the 52-week high.
- That makes 3 straight losses.
Oct 12, 2026 — OCS slides 5.5% to $7.88, a 52-week low
- Closed at $7.88, -5.52% vs the prior close of $8.34. Day range $7.85–$8.32, opened at $8.27.
- Volume was 283.60K shares, 1.2x its 50-day average of 239.50K.
- Price is -29.3% vs its 50-day average ($11.14) and -60.1% vs its 200-day average ($19.77).
- 52-week range $7.85–$34.47; today's close sits at 0% of that range, 77.1% below the 52-week high.
Oct 9, 2026 — OCS slides 3.7% to $8.34, a 52-week low
- Closed at $8.34, -3.70% vs the prior close of $8.66. Day range $8.30–$8.75, opened at $8.60.
- Volume was 161.90K shares, 0.7x its 50-day average of 245.76K.
- Price is -25.6% vs its 50-day average ($11.21) and -57.9% vs its 200-day average ($19.83).
- 52-week range $8.30–$34.47; today's close sits at 0% of that range, 75.8% below the 52-week high.
Oct 8, 2026 — OCS rises 1.9% to $8.66 on 1.9x normal volume
- Closed at $8.66, +1.88% vs the prior close of $8.50. Day range $8.37–$8.75, opened at $8.50.
- Volume was 452.00K shares, 1.9x its 50-day average of 240.63K — unusually heavy trading.
- Price is -23.2% vs its 50-day average ($11.27) and -56.5% vs its 200-day average ($19.89).
- 52-week range $8.30–$34.47; today's close sits at 1% of that range, 74.9% below the 52-week high.
Oct 7, 2026 — OCS dips 2.5% to $8.50, a 52-week low
- Closed at $8.50, -2.52% vs the prior close of $8.72. Day range $8.35–$8.83, opened at $8.83.
- Volume was 173.70K shares, 0.7x its 50-day average of 245.87K.
- Price is -24.9% vs its 50-day average ($11.31) and -57.4% vs its 200-day average ($19.95).
- 52-week range $8.30–$34.47; today's close sits at 1% of that range, 75.3% below the 52-week high.
Oct 6, 2026 — OCS rises 1.9% to $8.72
- Closed at $8.72, +1.87% vs the prior close of $8.56. Day range $8.30–$8.80, opened at $8.61.
- Volume was 291.60K shares, 1.2x its 50-day average of 247.63K.
- Price is -23.3% vs its 50-day average ($11.37) and -56.4% vs its 200-day average ($20.01).
- 52-week range $8.30–$34.47; today's close sits at 2% of that range, 74.7% below the 52-week high.
Oct 5, 2026 — OCS dips 1.9% to $8.56, a 52-week low, 3 down days in a row
- Closed at $8.56, -1.95% vs the prior close of $8.73. Day range $8.56–$9.00, opened at $8.79.
- Volume was 242.00K shares, 1.0x its 50-day average of 250.30K.
- Price is -25.0% vs its 50-day average ($11.41) and -57.3% vs its 200-day average ($20.06).
- 52-week range $8.53–$34.47; today's close sits at 0% of that range, 75.2% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — OCS dips 0.3% to $8.73, a 52-week low on 2.4x normal volume
- Closed at $8.73, -0.34% vs the prior close of $8.76. Day range $8.53–$8.82, opened at $8.82.
- Volume was 586.30K shares, 2.4x its 50-day average of 243.38K — unusually heavy trading.
- Price is -23.8% vs its 50-day average ($11.46) and -56.6% vs its 200-day average ($20.12).
- 52-week range $8.53–$34.47; today's close sits at 1% of that range, 74.7% below the 52-week high.
OCS latest news & SEC filings
Every SEC filing by or about OCS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 30, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 10, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 6, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 6, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 25, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade OCS
- How much it moves: over the last 20 sessions the average daily move was 3.14% (largest 6.7%). That is a volatile stock.
- Liquidity: about 326.51K shares (≈$2.38M) trade per day on average.
- 52-week position: $7.29 vs a range of $7.11–$34.47 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Sep 30, 2026; 6-K Aug 10, 2026; 6-K Aug 6, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
OCS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 7.33 | 7.46 | 7.16 | 7.29 | 293.68K |
| Oct 15, 2026 | 7.25 | 7.60 | 7.15 | 7.40 | 559.20K |
| Oct 14, 2026 | 7.51 | 7.74 | 7.11 | 7.17 | 511.40K |
| Oct 13, 2026 | 7.84 | 7.84 | 7.32 | 7.62 | 320.20K |
| Oct 12, 2026 | 8.27 | 8.32 | 7.85 | 7.88 | 283.60K |
| Oct 9, 2026 | 8.60 | 8.75 | 8.30 | 8.34 | 161.90K |
| Oct 8, 2026 | 8.50 | 8.75 | 8.37 | 8.66 | 452.00K |
| Oct 7, 2026 | 8.83 | 8.83 | 8.35 | 8.50 | 173.70K |
| Oct 6, 2026 | 8.61 | 8.80 | 8.30 | 8.72 | 291.60K |
| Oct 5, 2026 | 8.79 | 9.00 | 8.56 | 8.56 | 242.00K |
| Oct 2, 2026 | 8.82 | 8.82 | 8.53 | 8.73 | 586.30K |
| Oct 1, 2026 | 9.16 | 9.26 | 8.67 | 8.76 | 578.40K |
| Sep 30, 2026 | 9.20 | 9.48 | 9.02 | 9.34 | 434.70K |
| Sep 29, 2026 | 9.10 | 9.38 | 9.07 | 9.13 | 373.40K |
| Sep 28, 2026 | 9.20 | 9.33 | 9.00 | 9.06 | 267.00K |
| Sep 25, 2026 | 9.71 | 9.71 | 9.10 | 9.27 | 239.60K |
| Sep 24, 2026 | 9.94 | 9.94 | 9.21 | 9.41 | 209.20K |
| Sep 23, 2026 | 10.64 | 10.77 | 9.88 | 9.99 | 143.80K |
| Sep 22, 2026 | 10.27 | 10.84 | 10.26 | 10.71 | 206.70K |
| Sep 21, 2026 | 10.19 | 10.35 | 10.00 | 10.14 | 201.80K |
About Oculis Holding AG
Oculis Holding AG (OCS) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in ZUG, Switzerland. State of incorporation: Switzerland. Fiscal year ends December 31. SEC CIK 1953530.
OCS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
OCS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
OCS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on OCS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.